Doria, Khia B.

HRN: 27-74-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2025
CEFUROXIME 750MG (VIAL)
09/03/2025
09/10/2025
IV
260mg
Q8hours
Urinary Tract Infection
Checking Initial Appropriateness 
09/05/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/05/2025
09/12/2025
ORAL
3.5mL
Every 8hours
Intestinal Amoebiasis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: